BLOG
Better operational matrix to reflect in numbers - Hospitals Preview
What's Buzzing?
The hospitals universe under I-direct coverage is expected to reflect normalised quarter as pandemic driven positive/negative gyrations, festive impact are behind us. I-direct hospitals universe is expected to report sequential revenue growth of 1.6% in Q4FY23 to Rs 9,666 crore.
Context:
We expect performances to reflect optimum structural tailwinds of better case and payer mix, improved occupancies, better ARPOB and lower length of stay (ALOS). Similarly, international patient mix is expected to improve sequentially and is expected to touch/surpass pre-Covid levels. The sector, barring seasonality aspect in Q4, remains in good shape with focus on remunerative payer mix and case mix, higher emphasis on telemedicine, digital app based drives for treating patients at remote locations and incremental home-care treatments. Hospitals are expected to maintain capacity expansion drive via brownfield expansions and are expected to divulge more details about new greenfield capex cycle.
Our Perspective:
We are structurally positive on the hospitals space based on changes in payer mix with shift towards private insurance from government schemes, supported by changes in case mix with more complex procedures such as targeted oncology, transplants, cardiovascular and neurological procedures to have higher contribution. We note that substantial bed addition in FY15-19 took place in Tier II/III cities and as these beds attain break-even level, the same would have positive implications on financials. Medical tourism has bounced back to ~95% of pre Covid levels. Medical tourists account for 8-10% of the overall payer mix on a normalised basis. The average occupancy for I-direct Hospitals universe has improved on a continuous basis followed by improvement in blended ARPOB for our universe. Overall, we expect EBITDA of the I-direct hospital universe to increase 2.6% QoQ to Rs 1,461 crore whereas EBITDA margins are likely to grow 15 bps QoQ to 15.1%. Adjusted PAT of the I-direct hospital universe is expected to grow 9.1% QoQ to Rs 575 crore. Our top picks include: Narayana Hrudayalaya and Apollo Hospitals.
Disclaimer – I ICICI Securities Ltd. ( I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is acting as a distributor to solicit bond related products. All disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. Investments in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein mentioned are solely for informational and educational purpose.
Related content
Blogs
Articles - Stocks
Advantages and Disadvantages of NPS
It is a long established fact that a reader will be distracted by the readable content of a page when looking at it...
Articles - Stocks
Advantages and Disadvantages of NPS
It is a long established fact that a reader will be distracted by the readable content of a page when looking at it...
Articles - Stocks
Advantages and Disadvantages of NPS
It is a long established fact that a reader will be distracted by the readable content of a page when looking at it...
Video
Video - Stocks
What is Book Value?
Book Value Explained – Find out what is book value in stocks in this video by ICICIdirect.com.
Video - Stocks
What is Book Value?
Book Value Explained – Find out what is book value in stocks in this video by ICICIdirect.com.
Video - Stocks
What is Book Value?
Book Value Explained – Find out what is book value in stocks in this video by ICICIdirect.com.